Total 65Articles, Present Page 2/7
-
55Advisory Committee Meeting Outcomes on Candidate COVID-19 Treatment Napabeltan [Press Release, March 17, 2021]
-
(3.17) Advisory Committee Meeting Outcomes on Candidate COVID-19 Treatment Napabeltan.pdf
2021-03-23 -
-
54MFDS Grants Marketing Authorization for Pfizer Korea COVID-19 Vaccine [Press Release, Mar. 5, 2021]
-
(3.5) MFDS Grants Marketing Authorization for Pfizer Korea COVID-19 Vaccine.pdf
2021-03-19 -
-
53MFDS Begins Review of Janssen Korea’s COVID-19 Vaccine [Press Release Feb. 27, 2021]
-
(2.27) MFDS Begins Review of the Janssen COVID-19 Vaccine.pdf
2021-03-04 -
-
52The CPAC Meeting Outcome Regarding Pfizer’s COVID-19 Vaccine [Press Release, Feb. 26, 2021]
-
(2.26) CPAC Meeting Outcome Regarding Pfizes COVID-19 Vaccine.pdf
2021-03-04 -
-
51Advisory Committee Meeting Outcome on Pfzer's COVID-19 Vaccine [Press Release Feb. 23, 2021]
-
(2.23) Advisory Committee Meeting Outcome on Pfizer’s COVID-19 Vaccine.pdf
2021-03-02 -
-
50MFDS Approves the First National Lot Release of COVID-19 Vaccine [Press Release, Feb. 17, 2021]
-
2.17 National Lot Release of AstraZenecas COVID-19 Vaccine.pdf
2021-02-24 -
-
49MFDS grants Marketing Authorization for Korea AstraZeneca’s COVID-19 Vaccine [Press Release, Feb 10, 2021]
-
0210 Marketing Aurhorization for Korea AstraZeneca COVID19 vaccine.pdf
2021-02-10 -
-
48MFDS Begins Review of Pfizer’s COVID-19 Vaccine [Press Release, Jan 25, 2021]
-
(1.25) MFDS Begins Review of Pfizer’s COVID-19 Vaccine.pdf
2021-02-10 -
-
47Meeting Results of the Central Pharmaceutical Advisory Committee for COVID-19 Therapeutics [Press Release, Jan 27, 2021]
-
(1.27) Meeting Results of the Central Pharmaceutical Advisory Committee for COVID-19 Therapeutics.pdf
2021-02-10 -
-
46Updates on the approval and review of COVID19 therapeutics and vaccines (2) [Press Release, Jan 21, 2021]
-
(1.21) Updates on the approval and review of COVID19 therapeutics and vaccines.pdf
2021-02-10 -
